Apr 12, 2021 4:30pm EDT Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Apr 07, 2021 8:20pm EDT Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders
Apr 05, 2021 5:30pm EDT Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
Apr 05, 2021 4:05pm EDT Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range
Mar 15, 2021 8:05am EDT Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services
Mar 02, 2021 4:05pm EST Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance
Jan 28, 2021 4:15pm EST Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021
Nov 24, 2020 4:15pm EST Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
